Monteith, Scott
Glenn, Tasha
Geddes, John
Whybrow, Peter C.
Achtyes, Eric
Bauer, Michael
Article History
Accepted: 15 September 2022
First Online: 10 October 2022
Declarations
:
: EA has served on advisory boards or consulted for Alkermes, Atheneum, Janssen, Karuna, Lundbeck/Otsuka, Roche, Sunovion, and Teva and reports previous stock holdings in AstraZeneca, Johnson & Johnson, Moderna, and Pfizer. EA has received research support from Alkermes, Astellas, Biogen, Boehringer-Ingelheim, InnateVR, Janssen, National Network of Depression Centers, Neurocrine Biosciences, Novartis, Otsuka, Pear Therapeutics, and Takeda. EA serves as an advisor to CAPNOS Zero, the World Psychiatric Association and Clubhouse International, and the SMI Adviser LAI Center of Excellence (all unpaid). The other authors declare no competing interests.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
Free to read: This content has been made available to all.